International Plc Endo serves as Executive at BIOSPECIFICS TECHNOLOGIES CORP, where they oversee executive responsibilities. Since joining the company, International Plc Endo has executed 1 insider transactions totaling $650.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 2, 2020 involved purchasing 7,344,955 shares valued at $650.0M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 2, 2020 | BSTC | $650.0M | Purchase | 7,344,955 | $88.50 | Discretionary |
International Plc Endo currently holds 100 shares of BIOSPECIFICS TECHNOLOGIES CORP (BSTC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, International Plc Endo has been a net buyer of BSTC stock. They have purchased $650.0M and sold $0 worth of shares.
International Plc Endo's most recent insider trade was on Dec 2, 2020, when they purchased 7,344,955 shares at $88.50 per share.
Get notified when new Form 4 filings are submitted